General Richard Neal, Former U.S. Marine Corps Asst Commandant, Named as Director of Humanetics Corporation; Neal Brings Private Sector Experience with Defense-Related Companies to Board Position.MINNEAPOLIS -- Richard I. Neal Richard I. Neal is a retired United States Marine Corps four star general who served as Assistant Commandant of the Marine Corps (ACMC) from 1996 to 1998.
Neal was commissioned as a second lieutenant in the Marine Corps upon graduation in 1965 from Northeastern University, , the highly decorated four-star General and field commander whose most recent post was as Assistant Commandant of the United States Marine Corps United States Marine Corps (USMC)
Separate military service within the U.S. Department of the Navy (see U.S. Navy), charged with providing marine troops for seizure and defense of advanced bases and with conducting operations on land and in the air in connection with , was elected to the Humanetics Corporation Board of Directors, effective January 1, 2006, the Company announced today.
Neal, who retired from the U.S. Marine Corps in 1998, has extensive private sector experience in the area of intellectual property and in working with defense-related companies. This experience, combined with his background in strategic planning and organizational leadership, made him an attractive board candidate for the Company, according to Ronald Zenk, the Company's President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . Humanetics currently is working with various Department of Defense-affiliated organizations to develop oral countermeasures to ionizing radiation i·on·i·zing radiation
High-energy radiation capable of producing ionization in substances through which it passes.
Ionizing radiation resulting from a nuclear attack or dirty bomb.
"General Neal's knowledge of the U.S. military--as well as his experience in helping companies navigate the complexities of U.S. government contracts--will be of great assistance to Humanetics as we continue our work with the Department of Defense. We are delighted that General Neal has agreed to join our Board of Directors," Zenk said.
Neal said that he is pleased to be associated with Humanetics Corporation. "This is an exciting and growing company that is creating a new paradigm New Paradigm
In the investing world, a totally new way of doing things that has a huge effect on business.
The word "paradigm" is defined as a pattern or model, and it has been used in science to refer to a theoretical framework. in drug development," he said. "I'm looking forward to contributing to this effort as a board member."
Neal is President of Audio MPEG (Moving Pictures Experts Group) An ISO/ITU standard for compressing digital video. Pronounced "em-peg," it is the universal standard for digital terrestrial, cable and satellite TV, DVDs and digital video recorders (DVRs). , a patent licensing company located in Alexandria, Virginia and resides in Washington, D.C.
Humanetics Developing Radiation Countermeasures
Late last year, Humanetics was granted an exclusive worldwide license to further test, develop and commercialize an oral agent, BIO300, to strengthen and protect the immune system immune system
Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders. against exposure to ionizing radiation.
BIO300 was discovered by the National Institutes of Health and the Armed Forces Radiobiology Research Institute The Armed Forces Radiobiology Research Institute (AFRRI) is a triservice laboratory chartered by the U.S. Congress in 1961, conducts research in the field of radiobiology and related matters essential to the operational and medical support of the U.S. (AFRRI AFRRI Armed Forces Radiobiology Research Institute
AFRRI Appalachian Flood Risk Reduction Initiative ). Humanetics will collaborate on development of BIO300 with AFRRI, which is considered the country's premier center for radiation injury countermeasure research.
During 2005, Humanetics and AFRRI pursued a number of oral countermeasures, many of which have been shown effective in increasing survival in mice receiving otherwise lethal doses of radiation. Based on animal screening models, BIO300 emerged as the leading candidate for commercialization.
From Battlefield to Board Room
General Neal's four-star military career spanned nearly three decades, beginning in Vietnam in 1966 and continuing through Operation Desert Shield/Desert Storm in 1991. During that time, Neal served as Deputy of Operations at U.S. Central Command. From 1996-1998, Neal was the Assistant Commandant of the Marine Corps The Commandant of the United States Marine Corps is the highest ranking officer of the United States Marine Corps and a member of the Joint Chiefs of Staff, reporting to the Secretary of the Navy but not to the Chief of Naval Operations. , leading senior staff coordination, development and implementation of policy and financial plans for a 200,000 person organization and a $10.8 billion budget.
Since his retirement in 1998, Neal has served as a member of several Customer Advisory Boards and is on the Board of Directors for several defense-related companies.
Humanetics is a privately-held specialty pharmaceutical company headquartered in Minneapolis, Minnesota. The Company is focused on the rapid discovery, development and commercialization of orally-administered bioactive compounds for the prevention and treatment of diseases in categories with urgent and unmet needs. The Company has several proprietary compounds in preclinical and/or clinical stages of development in the areas of bioterrorism, Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. and obesity. For more information, visit: http://www.humaneticscorp.com.
This Press Release contains discussion of certain expectations regarding Humanetics' future performance. These forward-looking statements are based on the Company's current views and assumptions. Actual results could differ materially from these current expectations and projections, and from historical performance.